Americas Chemotherapy market

united states accounted for the largest market share in 2017 in the americas chemotherapy market, and is expected to reach usd 14599.22 million in 2024 from usd 7124.92 million in 2017. however, latin-america is the fastest growing market, which is expected to grow at a cagr of 11.16% during the forecast period 2018 - 2024. intravenous segment accounted for the largest market share in 2017, this market is expected to reach usd 10273.96 million in 2024 from usd 5121.08 million in 2017. this market is projected to grow at a cagr of 10.45% during the forecast period from 2018 - 2024. however, oral segment is the fastest growing market, which is expected to grow at a cagr of 11.33% during the forecast period 2018 - 2024. alkylating agents segment accounted for the largest market share in 2017, this market is expected to reach usd 8094.22 million in 2024 from usd 3879.50 million in 2017. this market is projected to grow at a cagr of 11.17% during the forecast period from 2018 - 2024. however, alkylating agents segment is the fastest growing market, which is expected to grow at a cagr of 11.17% during the forecast period 2018 - 2024. speciality centers segment accounted for the largest market share in 2017, this market is expected to reach usd 12952.82 million in 2024 from usd 6175.15 million in 2017. this market is projected to grow at a cagr of 11.16% during the forecast period from 2018 - 2024. however, speciality centers segment is the fastest growing market, which is expected to grow at a cagr of 11.16% during the forecast period 2018 - 2024. indication others segment accounted for the largest market share in 2017, this market is expected to reach usd 8148.12 million in 2024 from usd 4088.33 million in 2017. this market is projected to grow at a cagr of 10.35% during the forecast period from 2018 - 2024. however, breast cancer segment is the fastest growing market, which is expected to grow at a cagr of 11.33% during the forecast period 2018 - 2024.